Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2127-2134
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2127
Interaction between the albumin-bilirubin score and nutritional risk index in the prediction of post-hepatectomy liver failure
Feng-Fei Qin, Feng-Lian Deng, Cui-Ting Huang, Shu-Li Lin, Hui Huang, Jie-Jin Nong, Mei-Juan Wei
Feng-Fei Qin, Feng-Lian Deng, Hui Huang, Department of Infectious Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China
Cui-Ting Huang, Department of Renal Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China
Shu-Li Lin, School of Nursing, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China
Jie-Jin Nong, Department of Interventional Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China
Mei-Juan Wei, Department of Radiation Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China
Co-first authors: Feng-Fei Qin and Feng-Lian Deng.
Co-corresponding authors: Jie-Jin Nong and Mei-Juan Wei.
Author contributions: Qin FF and Deng FL, as co-first authors, designed and performed the research and wrote the manuscript; Huang CT and Lin SL collected experimental data and conducted statistical analyses; Huang H collected pathological specimens; Nong JJ and Wei MJ, as co-corresponding authors, provided funding and administrative support, provided guidance for the research, and revised the manuscript.
Supported by the Fourth Batch of Self-funded Projects of the Baise Scientific Research and Technology Development Plan in 2022, No. 20223734; and the 2023 National Key Research and Development Program: Research on Susceptibility Mechanisms and Screening Key Technologies for Major Viral Diseases, No. 2023YFC2605400.
Institutional review board statement: This study was approved by the Affiliated Hospital of Youjiang Medical University for Nationalities Institutional Review Committee.
Informed consent statement: This study was exempt from the requirement for informed consent due to the retrospective nature of the study.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Data sharing statement: Raw data for this study can be obtained from the corresponding author.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jie-Jin Nong, MBBS, Nurse, Department of Interventional Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshan Second Road, Youjiang District, Baise 533000, Guangxi Zhuang Autonomous Region, China. jiejinnong@163.com
Received: April 1, 2024
Revised: May 11, 2024
Accepted: June 4, 2024
Published online: July 27, 2024
Processing time: 111 Days and 22.5 Hours
Core Tip

Core Tip: This study investigated the relationship between the albumin-bilirubin (ALBI) score and nutritional risk index (NRI) in post-hepatectomy liver failure (PHLF). Of the 186 patients who underwent hepatectomy for hepatocellular carcinoma and were included in the study, 44 (23.66%) developed PHLF. Both the ALBI score and NRI were risk factors for PHLF, and there was an additive interaction between the ALBI score and NRI in PHLF. Patients with either of these risk factors should receive preventive pharmacological treatment and help with nutrition to reduce the risk of PHLF.